Cardiac Autoimmunity as a Novel Biomarker, Mediator, and Therapeutic Target of Heart Disease in Type 1 Diabetes

Patients with type 1 diabetes (T1D) suffer excess mortality from cardiovascular disease (CVD) that has persisted despite substantial reductions in microvascular complications. Although T1D and type 2 diabetes (T2D) are etiologically distinct, it has generally been assumed that CVD in T1D is “the sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipes, Myra A., Galderisi, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Diabetes, Other Diseases, and New Complications: Emerging Associations (JJ Nolan, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376963/
https://www.ncbi.nlm.nih.gov/pubmed/25821130
http://dx.doi.org/10.1007/s11892-015-0598-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376963/
https://www.ncbi.nlm.nih.gov/pubmed/25821130
http://dx.doi.org/10.1007/s11892-015-0598-1

Ejemplares similares